Comparison Between Oral Melatonin and Hydroxyzine in Pediatric Patients Undergoing Adenotonsillectomy
Launched by MINIA UNIVERSITY · Jan 10, 2023
Trial Information
Current as of May 24, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how effective two medications, oral Melatonin and Hydroxyzine, are in reducing anxiety in young children who are about to have a surgery called adenotonsillectomy, which involves removing the tonsils and adenoids. The goal is to see which medication better helps children feel calmer before their operation.
To participate in this study, children need to be between 3 and 10 years old, and they should be generally healthy, as those with chronic illnesses or developmental delays cannot join. If your child is chosen for the trial, they will receive either Melatonin or Hydroxyzine before their surgery to help with anxiety. It's important to know that children who have allergies to certain medications or conditions like acute porphyria will not be eligible to participate. If you think your child might qualify, this could be a helpful opportunity to support their comfort during a medical procedure.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. ASA: class l
- • 2. Sex: male and female
- • 3. Age: from 3 to 10 years old
- • 4. Children scheduled for adenotonsillectomy
- Exclusion Criteria:
- • 1. All children with a history of chronic illness, or developmental delay were excluded from the study
- • 2. History of an autoimmune disease
- • 3. Concurrent use of immunosuppressive treatment
- • 4. Sleep disturbances, speech or communication problems
- • 5. allergic to hydroxyzine, cetirizine, or other derivatives of piperazine, aminophylline, and ethylenediamine.
- • 6. hydroxyzine is contraindicated in patients with acute porphyria
- • -
About Minia University
Minia University is a prestigious educational institution located in Egypt, dedicated to advancing medical research and clinical trials. With a commitment to fostering innovation and improving healthcare outcomes, the university collaborates with a diverse range of stakeholders, including healthcare professionals and researchers. Minia University aims to enhance clinical practices through rigorous research methodologies and ethical standards, contributing to the body of knowledge in the medical field while addressing local and global health challenges. The university's clinical trial initiatives are designed to evaluate new treatments and interventions, ensuring a positive impact on patient care and community health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Al Minyā, , Egypt
Patients applied
Trial Officials
Sarah Omar
Study Director
Minia University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials